C. M. Williams

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Impact of Pre-Existing Immunity to Influenza on Live-Attenuated Influenza Vaccine (LAIV) Immunogenicity”.

Impact of Pre-Existing Immunity to Influenza on Live-Attenuated Influenza Vaccine (LAIV) Immunogenicity

Vaccines(2020)10.3390/vaccines8040683

N/A

0DataRank · unranked

21 citations

C. M. Williams, Danushka K. Wijesundara, Yoichi Furuya, Sreeja Biswas Roy

Impact of Pre-Existing Immunity on Live Attenuated Influenza Vaccine-Induced Cross-Protective Immunity

Vaccines(2020)10.3390/vaccines8030459

N/A

0DataRank · unranked

9 citations

C. M. Williams, Julián Pardo, Danushka K. Wijesundara, Yoichi Furuya, Sreeja Biswas Roy

A Triple-challenge Mouse Model of Allergic Airway Disease, Primary Influenza Infection, and Secondary Bacterial Infection

BIO-PROTOCOL(2020)10.21769/bioprotoc.3583

N/A

0DataRank · unranked

0 citations

C. M. Williams, Sreeja Biswas Roy, Yoichi Furuya, Sean Roberts

The Interleukin-33–Group 2 Innate Lymphoid Cell Axis Represents a Potential Adjuvant Target To Increase the Cross-Protective Efficacy of Influenza Vaccine

Journal of Virology(2021)10.1128/jvi.00598-21

N/A

0DataRank · unranked

15 citations

Sreeja Biswas Roy, Danielle Califano, Andrew N. J. McKenzie, Dennis W. Metzger, Yoichi Furuya +1 more

LUNG group 2 innate lymphoid cells as a new adjuvant target to enhance intranasal vaccine efficacy against influenza

Clinical & Translational Immunology(2022)10.1002/cti2.1381

N/A

0DataRank · unranked

4 citations

Sreeja Biswas Roy, Wei Sun, Andrea M Furuya, Danushka K. Wijesundara, Yoichi Furuya +1 more